CMMB Chemomab Therapeutics Ltd.
$2.58▼ -0.77%
Healthcare
Other
After hours
$2.55▼ -1.16%
Sep 11, 4:23 PM ET
Volume 100.7K
Avg Volume (10D) 110.6K
Key Metrics & Fundamentals
Market Cap
$18.91M
P/E Ratio
–
Div Yield
–%
52W Range
1.35 - 3.58
% vs 50 MA
28.24%
% vs 200 MA
40.03%
RSI-14
63.1
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.74
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.24M
COGS
–
Operating Exp
$2.24M
Operating Income
-$2.24M
EBIT
-$2.24M
Pretax Income
-$2.17M
Net Income
-$2.17M
EPS (Diluted)
-0.96
Price & Volume History
Loading chart…
Recent News
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
GlobeNewswire · Aug 31, 2026 12:00 PM
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 19, 2026 12:26 PM
Top Midday Decliners
MT Newswires · Jul 8, 2026 6:07 PM
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
GlobeNewswire · Jul 8, 2026 11:35 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CMMB's money flow as a full page
Social Sentiment
No Reddit posts found for CMMB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.